Takeda collaborates to launch wearable-tech depression study
February 23, 2017Medical Communications, Research and Development Takeda, depression, mental health, wearable tech
Takeda and Cognition Kit Limited have announced a collaborative venture to trial the use of an app in the monitoring …
BMS temporarily expands Board with three new additions
February 23, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb
Bristol-Myers Squibb has bolstered its Board of Directors with the appointment of three Directors, a move which temporarily expands its …
China’s insurance expansion boon to global pharma
February 23, 2017Sales and Marketing AstraZeneca, China, GSK, Shire
China has expanded the list of medicines that are covered on basic medical insurance schemes, named China’s National Reimbursement Drug …
Sun Pharma inaugurates first Egypt production facility
February 23, 2017Manufacturing and Production, Sales and Marketing Egypt, India, Ranbaxy, Sun Pharma
Ranbaxy, a subsidiary of India’s Sun Pharma, has opened its first production facility in Egypt in a bid to further …
First biosimilar for European cancer treatment given approval
February 23, 2017Sales and Marketing biosimilar, celltrion
The first biosimilar will be made available in Europe to match the indications of Roche’s best-selling cancer drug, Rituxan. The …
Novartis’ Zykadia scores priority review and breakthrough designation from FDA
February 23, 2017Sales and Marketing Novartis, zykadia
Novartis’ lung cancer treatment Zykadia (ceritinib) has been awarded both priority review and breakthrough therapy designation by the US Food …
CSO loses position at DNA sequencing company after admitting fraud
February 23, 2017Medical Communications Karmagenes
Pranav Ullal, formerly of Chief Scientific officer of Karmagenes, has been removed from his position after a paper he published …
Pfizer’s Remicade biosimilar displays similar efficacy
February 22, 2017Research and Development Johnson & Johnson, Pfizer, Remicade, inflectra
Pfizer and Celltrion have announced new data for their Remicade biosimilar, Inflectra, that shows that the drug is comparable in …
Insider Interview: BGMA Director Warwick Smith disputes recent generic price increase claims
February 22, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Warwick Smith, bgma, generics
Warwick Smith, Director of the British Generic Manufacturer’s Association (BGMA), discusses the recent data suggesting generic drug prices in the …
Roche and Discuva extend agreement to develop target antimicrobials
February 22, 2017Research and Development, Sales and Marketing Discuva, Roche
Discuva, a drug discovery company based in Cambridge, UK, has announced that its collaboration with Roche, first agreed in 2014, …
Rabbit virus proves effective in treatment of multiple myeloma
February 22, 2017Research and Development multiple myeloma
A team of researchers at the Medical University of South Carolina (MUSC) utilising the myxoma virus (MYXV) to treat multiple …
Testosterone gel trials reveal mixed results of benefits and drawbacks
February 22, 2017Research and Development Testosterone gel, testosterone
A large study looking into the potential positive or negative effects of supplementing older men with testosterone gel revealed definitive …
Nativis bolsters boardroom with new director
February 22, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Nativis
Nativis Inc., a clinical stage life science bio-electronic company, has announced the appointment of Dr Una Ryan to its board …
The March 2017 issue of Pharmafocus is now live!
February 22, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actelion, FDA, Johnson & Johnson, MSD, Roche, Trump, crispr, immunotherapy, opdivo
The latest edition of Pharmafocus is available to read online now! From breakthroughs in antibiotic resistance R&D to gene editing …
FDA Priority Review for Pfizer investigational leukaemia drug
February 22, 2017Research and Development, Sales and Marketing EMA, FDA, Inotuzumab ozogamicin, Pfizer, priority review
Pfizer has announced that its leukaemia treatment inotuzumab ozogamicin has been accepted for Priority Review by the US Food and …
FDA rejects Amphastar’s application for NDA for intranasal overdose treatment
February 21, 2017Research and Development Amphastar, FDA
Amphastar has received a Complete Response Letter (CRL) for its New Drug Application (NDA) for an intranasal version of Naloxone, …
Anti-aging study reveals role of mitochondria pointing towards new medicine
February 21, 2017Manufacturing and Production, Research and Development Anti-aging, SkQ1, anti aging, mitochondria
A joint study between researchers from Russia and Sweden has revealed the extent to which mitochondria play a role in …
NICE provisionally rejects Ipsen’s kidney cancer drug Cabometyx
February 21, 2017Manufacturing and Production, Sales and Marketing Cometriq, NICE, ipsen
NICE has announced draft guidance for Ipsen’s cancer drug Cabometyx (cabozantinib), revealing it does not recommend the drug for use on …
Faulty batch of Takeda’s paracetamol discovered in Denmark
February 21, 2017Manufacturing and Production Denmark, Takeda
Takeda has announced a recall of a batch of its paracetamol tablets, named Pamol, in Denmark after two packs were …
Merck eyes new India bio-production facility
February 21, 2017Manufacturing and Production Merck
German pharmaceutical firm Merck has made it known that it has plans to expand its operations in India with a …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
